132 related articles for article (PubMed ID: 29445546)
1. Circulating Angiogenic Growth Factors in Diabetes Patients with Peripheral Arterial Disease and Exertional Leg Pain in Ghana.
Yeboah K; Agyekum JA; Baafour EK; Antwi DA; Adjei AB; Boima V; Gyan B
Int J Vasc Med; 2017; 2017():2390174. PubMed ID: 29445546
[TBL] [Abstract][Full Text] [Related]
2. Peripheral artery disease and exertional leg symptoms in diabetes patients in Ghana.
Yeboah K; Puplampu P; Ainuson J; Akpalu J; Gyan B; Amoah AG
BMC Cardiovasc Disord; 2016 Apr; 16():68. PubMed ID: 27093857
[TBL] [Abstract][Full Text] [Related]
3. Leg symptoms in peripheral arterial disease: associated clinical characteristics and functional impairment.
McDermott MM; Greenland P; Liu K; Guralnik JM; Criqui MH; Dolan NC; Chan C; Celic L; Pearce WH; Schneider JR; Sharma L; Clark E; Gibson D; Martin GJ
JAMA; 2001 Oct; 286(13):1599-606. PubMed ID: 11585483
[TBL] [Abstract][Full Text] [Related]
4. Exertional leg symptoms other than intermittent claudication are common in peripheral arterial disease.
McDermott MM; Mehta S; Greenland P
Arch Intern Med; 1999 Feb; 159(4):387-92. PubMed ID: 10030313
[TBL] [Abstract][Full Text] [Related]
5. Leg symptoms, the ankle-brachial index, and walking ability in patients with peripheral arterial disease.
McDermott MM; Mehta S; Liu K; Guralnik JM; Martin GJ; Criqui MH; Greenland P
J Gen Intern Med; 1999 Mar; 14(3):173-81. PubMed ID: 10203623
[TBL] [Abstract][Full Text] [Related]
6. Exertional leg pain in patients with and without peripheral arterial disease.
Wang JC; Criqui MH; Denenberg JO; McDermott MM; Golomb BA; Fronek A
Circulation; 2005 Nov; 112(22):3501-8. PubMed ID: 16316971
[TBL] [Abstract][Full Text] [Related]
7. Exercise performance in patients with peripheral arterial disease who have different types of exertional leg pain.
Gardner AW; Montgomery PS; Afaq A
J Vasc Surg; 2007 Jul; 46(1):79-86. PubMed ID: 17540534
[TBL] [Abstract][Full Text] [Related]
8. Circulating angiogenic factors in diabetes patients in a tertiary hospital in Ghana.
Yeboah K; Kyei-Baafour E; Antwi DA; Asare-Anane H; Gyan B; Amoah AG
J Diabetes Metab Disord; 2016; 15():44. PubMed ID: 27777900
[TBL] [Abstract][Full Text] [Related]
9. Elevated Proangiogenic Markers are Associated with Vascular Complications within Ghanaian Sickle Cell Disease Patients.
Antwi-Boasiako C; Frimpong E; Gyan B; Kyei-Baafour E; Sey F; Dzudzor B; Abdul-Rahman M; Dankwah GB; Otu KH; Ndanu TA; Campbell AD; Ekem I; Donkor ES
Med Sci (Basel); 2018 Jun; 6(3):. PubMed ID: 29954157
[No Abstract] [Full Text] [Related]
10. Peripheral sensory neuropathy is associated with circulating angiopoietins in type 2 diabetes patients in Ghana.
Agyekum JA; Yeboah K
J Clin Transl Endocrinol; 2023 Dec; 34():100327. PubMed ID: 37822668
[TBL] [Abstract][Full Text] [Related]
11. Angiopoietin-2 Is Associated with Aortic Stiffness in Diabetes Patients in Ghana: A Case-Control Study.
Agyekum JA; Yeboah K
Int J Vasc Med; 2023; 2023():3155982. PubMed ID: 37869582
[TBL] [Abstract][Full Text] [Related]
12. Peripheral artery disease, diabetes, and reduced lower extremity functioning.
Dolan NC; Liu K; Criqui MH; Greenland P; Guralnik JM; Chan C; Schneider JR; Mandapat AL; Martin G; McDermott MM
Diabetes Care; 2002 Jan; 25(1):113-20. PubMed ID: 11772911
[TBL] [Abstract][Full Text] [Related]
13. Lower-leg symptoms in peripheral arterial disease are associated with anxiety, depression, and anhedonia.
Smolderen KG; Hoeks SE; Pedersen SS; van Domburg RT; de Liefde II; Poldermans D
Vasc Med; 2009 Nov; 14(4):297-304. PubMed ID: 19808714
[TBL] [Abstract][Full Text] [Related]
14. Leg symptom categories and rates of mobility decline in peripheral arterial disease.
McDermott MM; Ferrucci L; Liu K; Guralnik JM; Tian L; Liao Y; Criqui MH
J Am Geriatr Soc; 2010 Jul; 58(7):1256-62. PubMed ID: 20550604
[TBL] [Abstract][Full Text] [Related]
15. Are cardiovascular function and habitual physical activity levels similar in patients with classic and atypical claudication symptoms? A cross-sectional study.
Longano P; Kanegusuku H; Correia MA; Puech-Leao P; Wolosker N; Cucato GG; Ritti-Dias RM
Vascular; 2020 Aug; 28(4):360-367. PubMed ID: 32212916
[TBL] [Abstract][Full Text] [Related]
16. Impact of type 2 diabetes on the plasma levels of vascular endothelial growth factor and its soluble receptors type 1 and type 2 in patients with peripheral arterial disease.
Wieczór R; Gadomska G; Ruszkowska-Ciastek B; Stankowska K; Budzyński J; Fabisiak J; Suppan K; Pulkowski G; Rość D
J Zhejiang Univ Sci B; 2015 Nov; 16(11):948-56. PubMed ID: 26537213
[TBL] [Abstract][Full Text] [Related]
17. Plasma levels of soluble Tie2 and vascular endothelial growth factor distinguish critical limb ischemia from intermittent claudication in patients with peripheral arterial disease.
Findley CM; Mitchell RG; Duscha BD; Annex BH; Kontos CD
J Am Coll Cardiol; 2008 Jul; 52(5):387-93. PubMed ID: 18652948
[TBL] [Abstract][Full Text] [Related]
18. Stenting for peripheral artery disease of the lower extremities: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(18):1-88. PubMed ID: 23074395
[TBL] [Abstract][Full Text] [Related]
19. Self-reported symptoms on questionnaires and anatomic lesions on duplex ultrasound examinations in patients with peripheral arterial disease.
van Zitteren M; Vriens PW; Heyligers JM; Burger DH; Nooren MJ; de Fijter WM; Denollet J; Smolderen KG
J Vasc Surg; 2012 Apr; 55(4):1025-1034.e2. PubMed ID: 22244858
[TBL] [Abstract][Full Text] [Related]
20. Abnormal angiopoietins 1&2, angiopoietin receptor Tie-2 and vascular endothelial growth factor levels in hypertension: relationship to target organ damage [a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)].
Nadar SK; Blann A; Beevers DG; Lip GY
J Intern Med; 2005 Oct; 258(4):336-43. PubMed ID: 16164572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
